Home Rainmed Medical: Building a Lean Production and Digital Management System to Support the Implementation of Its Vascular Interventional Robotics Strategy

Rainmed Medical: Building a Lean Production and Digital Management System to Support the Implementation of Its Vascular Interventional Robotics Strategy

Dec 23, 2021 10:55 CST Updated 10:55
To become a global leader in vascular interventional surgical robotics, Rainmed Medical has continuously engaged in R&D and successively launched a series of key modules and related products, establishing a global network for research and development, manufacturing, sales, and services.Behind the company’s rapid development and swift commercialization, its product supply chain, manufacturing, and quality control systems have progressively matured and been refined, fully supporting the production of both commercialized products and those under development, thereby enabling the implementation of the company’s strategy for vascular interventional surgical robots.

7.png

Production Scenes at Rainmed Medical’s Workshop


“Innovation” and “Breakthrough” are ingrained in the DNA of Rainmed Medical. This is reflected not only in product development but also permeates the entire end-to-end process, including sales demand management, planning, material procurement, incoming quality control, warehouse management, manufacturing, quality inspection, and logistics distribution. Currently,RainMed Medical has established precision manufacturing workshops and a digital management system, providing robust backend support to stabilize product quality, ensure production schedules, enhance overall capacity, and sustain the company’s strong competitiveness.


Robust and Standardized Production Systems Bolster the Leading Position of Domestically Produced Coronary Diagnostic Solutions


As part of the digital functional diagnostic module for future vascular interventional surgical robots, Rainmed Medical’s coronary angiography-derived fractional flow reserve (caFFR) system has been launched on the market and can be used independently for the precise diagnosis of coronary artery disease. Currently, the caFFR system is in use at more than 700 hospitals across China, has received widespread acclaim from clinical operators, and continues to see rising sales, leading the domestic FFR product market. Furthermore, Rainmed Medical has achieved a breakthrough by becoming the first Chinese manufacturer to export FFR products, establishing distribution networks in Europe, Africa, Southeast Asia, and other regions.


The company already has two major production bases, with a total area of over 6,000 square meters.It is expected to be fully operational by early 2022, at which time the maximum annual production capacity for equipment will exceed 10,000 units, and that for consumables will surpass one million sets.Furthermore, to ensure timely and efficient product sales, Rainmed’s medical supply chain department has established a robust supply chain management system by focusing on three key dimensions: demand management, professional planning, and product delivery. This approach enables rational allocation of requests, rapid response to demands, and demonstrates exceptional delivery capabilities within shorter production cycles.


3.png

Production Scenes at Rainmed Medical's Workshop


Runmaide Medical’s manufacturing facility strictly adheres to the national Good Manufacturing Practice (GMP) requirements for medical devices to ensure compliant production, establishes a high-standard operational environment, recruits top-tier technical talent, and drives high-quality manufacturing. The company continuously improves production processes, optimizes manufacturing equipment, and acceptsNational Medical Products Administration (NMPA) and European Medicines Agency (EMA)Regular inspections by factory standard regulatory authorities provide a safe working environment for achieving high-quality product manufacturing.


It is worth mentioning that, under stringent production requirements,Rainmed Medical has successfully passed the MDSAP five-country certification standards, obtaining regulatory approvals compliant with the standards and regulations of Australia, Brazil, Canada, Japan, and the United States.The MDSAP certification requirements are extremely stringent. Successfully meeting the MDSAP certification standards of the five participating countries represents the highest recognition of Rainmed Medical’s production quality, management level, and capabilities. This certification will facilitate the expansion of Rainmed Medical’s products into the markets of these five countries and even globally, providing assurance for expanding its international business footprint and fully preparing the company to open up the international market.


Quality is the soul of enterprise production. Rainmed Medical places high importance on product quality control, emphasizes customer complaint analysis, establishes a closed-loop quality inspection system, and drives product upgrades and improvements. Rainmed Medical has invested substantial resources to implement strict quality control across all stages, including design, research and development, production, testing, and transportation of both existing and candidate products, while establishing a robust after-sales feedback mechanism. By conducting professional analysis of multi-channel customer complaints, holding review meetings, and implementing feedback-driven improvements, the company continuously promotes product updates and iterations. In 2021, Rainmed Medical maintained its valid customer complaint rate at an extremely low level, reflecting that its current production and quality control standards have reached an industry-leading position.


Advanced Intelligent Management Methods for Building a World-Class Manufacturing System


Currently, the outstanding diagnostic capabilities of Runmaide’s series of angiography products have been authoritatively validated by clinical studies in multiple countries and widely acclaimed by clinicians, attracting attention and support from top-tier investors, technology companies, logistics platforms, and hospital groups. To better meet the growing demand for production capacity,RainMed Medical has added a new production base, increasing its production capacity by 10 times.Meanwhile, Rainmed Medical has broken through the previous production management model,Implement digital, automated, and intelligent improvements across all production stages to enhance the level of refined workshop management., laying a solid foundation for achieving a leap in production capacity.


4.jpg

Production Footage from Rainmed Medical’s Workshop


In terms of digitalization,The production supply chain is about to implement a Manufacturing Execution System (MES), significantly enhancing the speed and accuracy of material and product traceability, enabling scientific management of labor hours, reducing delays and error rates in data entry caused by human factors during production, shortening delivery lead times, and promptly responding to market changes, thereby proactively advancing the level of refined workshop management.


In terms of automation,The workshop has established an automated production assembly line, integrating processes from raw material assembly to product packaging to achieve fully automated manufacturing. It is advancing fully automated high-voltage testing and automated product inspection procedures to increase production capacity and ensure consistent quality. Meanwhile, to enhance software compatibility and better support front-end software installation and terminal software adaptation, the production workshop will implement a one-click software configuration feature, thereby advancing the strategic objective of building Rainmed’s platform-level medical products.


In terms of intelligence,Driven by continuous improvements in production capacity, facility infrastructure, BOM accuracy, and factory intelligence, Rainmed Medical will launch an unmanned material delivery system. This initiative underscores the company’s exceptional process design capabilities and lean manufacturing proficiency. Reportedly, only a handful of companies in China’s medical sector have implemented automated material delivery systems for production lines. Rainmed Medical’s unmanned delivery system sets a benchmark for smart factory construction within the industry, leading the trend toward intelligent manufacturing in the medical device sector.


A High-End, Premium Technical Team to Build an Industry Production Demonstration Base


The Company's Production Quality Control Team'sSenior technical management members all come from top medical device companies in the industry such as Philips, Siemens, and Mindray, and have more than 5 years of management experience.The addition of top-tier technical talent has brought advanced management expertise and innovative production models to Rainmed Medical’s production team, while also strengthening the internal employee training system, thereby cultivating a high-caliber, comprehensive production service team for Rainmed Medical.


In addition to system construction, the production services team emphasizes internal talent development, striving to build a youthful, diversified, and dynamic production workforce. Rainmed Medical’s achievements in supply chain management, manufacturing, and quality control systems have established a technological highland in Suzhou and beyond, continuously attracting industry peers for visits and study tours, and earning high recognition from the Administrative Committee of Suzhou Industrial Park. The Administrative Committee of Suzhou Industrial Park publicly commended Rainmed Medical’s remarkable “overtaking on the bend” on its official website, while Suzhou Broadcasting System has conducted multiple interviews and reports highlighting Rainmed Medical’s advanced production capabilities. These accolades underscore the advanced nature and industry-leading status of Rainmed Medical’s production services. Currently, Rainmed Medical’s comprehensive strength continues to strengthen, meeting the growing clinical demands and the needs of an increasingly diverse product pipeline.


In the future, the company will continue to increase its investments in supply chain, manufacturing, and quality control, enhance overall production and service capabilities, support the strategic implementation of vascular interventional surgical robots, continuously meet domestic and international market demands, and bring the benefits of Chinese intelligent manufacturing to patients with vascular diseases worldwide!


5.png

RainMed Medical Vascular Interventional Surgical Robot